Protein Sciences announced that the FDA has approved and released the first lots of Flublok® influenza vaccine for distribution this season. Doses have been shipped and healthcare professionals and pharmacies that have pre-ordered Flublok will be receiving the vaccine shortly.
The company’s Flublok website incorporates a ‘Flublok Finder’ that allows consumers to locate a convenient Flublok location. See https://www.flublok.com/get-flublok/flublok-finder/.
“With early release of Flublok, we will be one of the first vaccines available to protect adults,” said Manon Cox, President and CEO of Protein Sciences.